Berger Montague is on the executive committee of this wage-fixing case (Brown v. JBS USA Food Company, et al.) against numerous red meat processing plants. Pending final approval, there have been $200...
Berger Montague is on the executive committee of this pay depression case filed on behalf of non-supervisory production and maintenance employees at chicken processing plants. There are $339 million...
Berger Montague is co-lead counsel in this antitrust class action against several defendants, including HCA Healthcare, one of the nation’s largest for-profit hospital networks, that owns and...
Berger Montague is co-lead counsel representing a class of contract chicken farmers (also called “growers”) in a pay suppression case alleging that the major chicken processing companies conspired...
Berger Montague represents a former Canadian Hockey League (CHL) player in an antitrust class action against the National Collegiate Athletics Association (NCAA) and ten of its member institutions....
Overview Berger Montague, a leader in antitrust litigation, has been fighting Merck over their antitrust activities for several years now. We’re pleased to announce that in our ongoing case...
The Participants in the Lawsuit. Osterhaus Pharmacy is representing a proposed class of pharmacies against CVS Caremark, the largest pharmacy benefit manager (“PBM”) in the country. Berger...
Berger Montague serves as Co-Lead Class Counsel representing classes of All-Star Cheer Gyms and Spectators of All Star Cheer Events in antitrust litigation against Varsity Brands, LLC and its...
Berger Montague serves as co-lead counsel and obtained over $200 million in settlements to date in this antitrust class action lawsuit filed against Brown University, California Institute of...
Berger Montague served as co-lead counsel and obtained settlements totaling $531 million on behalf of a class of direct purchasers of high fructose corn syrup, the principal sweetener used in non-diet...
Berger Montague served as one of the lead trial counsel obtaining over $604.5 million in settlements on behalf of a class of direct purchasers of aluminum and tantalum electrolytic capacitors and film...
Berger Montague served as Co-Lead Counsel and obtained a $190.7 million settlement on behalf of a class of direct purchasers of drywall, in a case alleging that the dominant manufacturers of drywall...
Berger Montague currently serves as a member of the Interim Class Counsel Executive Committee on behalf of a proposed class of direct purchasers of brand or generic versions of Effexor XR from Wyeth...
Berger Montague represented a certified class of employees suing technology and media giants including Apple Inc., Google Inc., Intel Corp., Adobe Systems Inc., Intuit Inc., Pixar Animation Studios...
Berger Montague served as Co-Lead Counsel and obtained $62.3 million in total settlements for a class of direct purchasers of the brand-name drug K-Dur 20, a potassium chloride supplement used to...
Berger Montague represents plaintiffs who purchased the prescription drug Lamictal or generic Lamictal in antitrust litigation pending in the United States District Court for the District of New...
Berger Montague served on the Executive Committee and obtained a $202 million settlement in this nationwide antitrust class action against the producers of linerboard. The plaintiffs alleged that the...
Berger Montague currently serves as Co-Lead Counsel on behalf of a class of direct purchasers of brand or generic versions of the prescription drug Lipitor from Pfizer (Pfizer Manufacturing Ireland,...
Berger Montague served as co-lead counsel and obtained a $120 million settlement for the class of direct purchasers of brand Loestrin, generic Loestrin, and brand Minastrin. The direct purchaser class...
Berger Montague served as co-lead counsel and obtained a $750 million settlement on behalf of a class of direct purchasers of branded and/or generic Namenda IR and/or branded Namenda XR, from Forest...
Berger Montague serves as co-lead counsel in this class action challenging an alleged pay-for-delay arrangement concerning the brand name drug Niaspan (extended-release niacin). The case is pending in...
Berger Montague served as co-lead counsel and obtained over $76.8 million in total settlements on behalf of a class of direct purchasers of brand and generic Solodyn (extended-release minocycline...
Berger Montague represented a certified class of direct purchaser plaintiffs who purchased Suboxone tablets directly from defendant Reckitt Benckiser Pharmaceuticals, Inc. (now known as Indivior...
Berger Montague served on the Plaintiffs’ Executive Committee which obtained over $473 million in total settlements in In re TFT-LCD Antitrust Litigation, an antitrust class action against the...
Berger Montague served as class counsel and obtained settlements totaling $163.5 million on behalf of direct purchasers of titanium dioxide, a product used in paints, inks and other applications. The...
Berger Montague served as class counsel and obtained a $250 million settlement on behalf of a class of direct purchasers of the cholesterol drug Tricor in this antitrust litigation. The plaintiffs...
Berger Montague served as Plaintiffs’ Co-Lead Counsel and obtained total settlements of $152 million in this class action antitrust lawsuit alleging that the five banks that participated in the...
Berger Montague serves on the Plaintiffs’ Steering Committee for a proposed class of generic drug purchasers in price-fixing and market allocation litigation brought against many of the generic drug...
Berger Montague served as class counsel and recovered $187 million in combined settlements on behalf of investors who transacted in Eurodollar futures contracts and options on futures contracts on the...
Berger Montague served as co-lead class counsel and obtained a $145 million settlement in this antitrust pay for delay action on behalf of a certified class of direct purchasers of brand or generic...
Berger Montague is co-lead counsel and obtained a $20 million settlement in these consolidated class actions on behalf of traders of platinum and palladium-based derivative contracts, physical...
Berger Montague served as co-lead counsel and obtained a $12.6 million settlement for direct purchasers of filled propane tanks from the defendants AmeriGas and Ferrellgas LP (which does business as...
Berger Montague served as class counsel and obtained a $51.25 million settlement for the class of direct purchasers of the prescription drug Restasis in this antitrust class action litigation against...
Berger Montague served as counsel in this case and helped obtain total settlements of $193.9 million for a class of direct purchasers of steel products from the eight largest steel manufacturers in...
Berger Montague served on the Executive Committee and obtained total settlements of over $512 million in this antitrust pay for delay class action on behalf of direct purchasers of modafinil, a...
Berger Montague represented the City and County of Denver, served on the Plaintiffs’ Steering Committee, and obtained settlements totaling $90.5 million in this antitrust litigation on behalf of...
Berger Montague served as co-lead counsel and obtained settlements totaling $130 million for a class of 6,500 independent truck stops and other retail fueling facilities in this antitrust lawsuit. The...
Berger Montague served as class counsel in this antitrust class action, winning a $190 million settlement on behalf of a class of direct purchasers of the brand-name prescription drug Neurontin. The...
Berger Montague serves as Co-Lead Counsel and has obtained a $5.6 billion antitrust settlement for a national class of direct purchasers in the Payment Card Interchange Fee and Merchant Discount...
Berger Montague served as lead counsel and obtained a $49.5 million settlement of plaintiffs’ claims concerning the imposition of foreign transaction fees. The case was litigated in the United...
Berger Montague served as lead counsel for the cardholder classes and obtained settlements with four of the nation’s largest credit card companies, JPMorgan Chase, Bank of America, Capital One and...
Berger Montague’s team, led by David F. Sorensen, represents a class of direct purchasers of the drug Zetia (ezetimibe). Plaintiffs allege that Merck & Co. Inc., Merck Sharp & Dohme Corp.,...
Berger Montague served as Co-Lead Counsel and obtained a $717 million settlement in this antitrust price-fixing class action on behalf of a class of purchasers of brand name prescription drugs. Led by...
Berger Montague served as co-lead class counsel and obtained a $61.5 million settlement on behalf of a class of physicians and other direct purchasers of vaccines from defendant Sanofi Pasteur Inc....
Berger Montague represented the plaintiffs and played a key role in obtaining $211.7 million in settlements in In re CRT Antitrust Litigation, a case brought on behalf of a class of direct...
Berger Montague served as class counsel and obtained a $94 million settlement for the class of direct purchasers of brand and generic Celebrex (celecoxib) in this antitrust action against Pfizer. The...
Berger Montague served as counsel for the direct purchasers of containerboard products and obtained settlements of more than $350 million. In this litigation, the plaintiffs alleged that from 2004 to...
Berger Montague, led by Michael Dell’Angelo, served as lead class counsel and obtained $23.63 million in settlements with the defendants in the multistate indirect purchaser antitrust class...
Led by Eric L. Cramer, Michael Dell’Angelo, and Patrick F. Madden, Berger Montague serves as co-lead counsel on behalf of a certified class of UFC fighters who fought for the UFC between December...
Berger Montague served as Co-Lead Counsel and obtained a $336 million settlement in this historic antitrust case alleging that the major credit cards and defendant banks conspired to fix prices for...
Berger Montague served as co-lead counsel and obtained an $80 million settlement for a class of dental practices and dental laboratories in this antitrust lawsuit against Henry Schein, Inc., Patterson...